178 related articles for article (PubMed ID: 25702787)
1. Epidermal growth factor receptor and AKT1 gene copy numbers by multi-gene fluorescence in situ hybridization impact on prognosis in breast cancer.
Li J; Su W; Zhang S; Hu Y; Liu J; Zhang X; Bai J; Yuan W; Hu L; Cheng T; Zetterberg A; Lei Z; Zhang J
Cancer Sci; 2015 May; 106(5):642-9. PubMed ID: 25702787
[TBL] [Abstract][Full Text] [Related]
2. EGFR gene copy number increase in vulvar carcinomas is linked with poor clinical outcome.
Woelber L; Hess S; Bohlken H; Tennstedt P; Eulenburg C; Simon R; Gieseking F; Jaenicke F; Mahner S; Choschzick M
J Clin Pathol; 2012 Feb; 65(2):133-9. PubMed ID: 22128196
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up.
Rydén L; Jirström K; Haglund M; Stål O; Fernö M
Breast Cancer Res Treat; 2010 Apr; 120(2):491-8. PubMed ID: 20135347
[TBL] [Abstract][Full Text] [Related]
4. EGFR, HER2, survivin, and loss of pSTAT3 characterize high-grade malignancy in salivary gland cancer with impact on prognosis.
Ettl T; Stiegler C; Zeitler K; Agaimy A; Zenk J; Reichert TE; Gosau M; Kühnel T; Brockhoff G; Schwarz S
Hum Pathol; 2012 Jun; 43(6):921-31. PubMed ID: 22154363
[TBL] [Abstract][Full Text] [Related]
5. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.
Chung CH; Ely K; McGavran L; Varella-Garcia M; Parker J; Parker N; Jarrett C; Carter J; Murphy BA; Netterville J; Burkey BB; Sinard R; Cmelak A; Levy S; Yarbrough WG; Slebos RJ; Hirsch FR
J Clin Oncol; 2006 Sep; 24(25):4170-6. PubMed ID: 16943533
[TBL] [Abstract][Full Text] [Related]
6. Molecular alterations in AKT and its protein activation in human lung carcinomas.
Dobashi Y; Kimura M; Matsubara H; Endo S; Inazawa J; Ooi A
Hum Pathol; 2012 Dec; 43(12):2229-40. PubMed ID: 22748472
[TBL] [Abstract][Full Text] [Related]
7. EGFR gene copy number alteration is a better prognostic indicator than protein overexpression in oral tongue squamous cell carcinomas.
Nakata Y; Uzawa N; Takahashi K; Sumino J; Michikawa C; Sato H; Sonoda I; Ohyama Y; Okada N; Amagasa T
Eur J Cancer; 2011 Oct; 47(15):2364-72. PubMed ID: 21852109
[TBL] [Abstract][Full Text] [Related]
8. Relationship between epidermal growth factor receptor gene copy number and protein expression in oral cavity squamous cell carcinoma.
Huang SF; Cheng SD; Chien HT; Liao CT; Chen IH; Wang HM; Chuang WY; Wang CY; Hsieh LL
Oral Oncol; 2012 Jan; 48(1):67-72. PubMed ID: 21831696
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.
Schlomm T; Kirstein P; Iwers L; Daniel B; Steuber T; Walz J; Chun FH; Haese A; Kollermann J; Graefen M; Huland H; Sauter G; Simon R; Erbersdobler A
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6579-84. PubMed ID: 18006757
[TBL] [Abstract][Full Text] [Related]
10. Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers.
Toyama T; Yamashita H; Kondo N; Okuda K; Takahashi S; Sasaki H; Sugiura H; Iwase H; Fujii Y
BMC Cancer; 2008 Oct; 8():309. PubMed ID: 18950515
[TBL] [Abstract][Full Text] [Related]
11. Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study.
Hirsch FR; Varella-Garcia M; McCoy J; West H; Xavier AC; Gumerlock P; Bunn PA; Franklin WA; Crowley J; Gandara DR;
J Clin Oncol; 2005 Oct; 23(28):6838-45. PubMed ID: 15998906
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma.
Valsecchi ME; McDonald M; Brody JR; Hyslop T; Freydin B; Yeo CJ; Solomides C; Peiper SC; Witkiewicz AK
Cancer; 2012 Jul; 118(14):3484-93. PubMed ID: 22086503
[TBL] [Abstract][Full Text] [Related]
13. EGFR and AKT1 overexpression are mutually exclusive and associated with a poor survival in resected gastric adenocarcinomas.
Petrini I; Lencioni M; Vasile E; Fornaro L; Belluomini L; Pasquini G; Ginocchi L; Caparello C; Musettini G; Vivaldi C; Caponi S; Ricci S; Proietti A; Fontanini G; Naccarato AG; Nardini V; Santi S; Falcone A
Cancer Biomark; 2018 Feb; 21(3):731-741. PubMed ID: 29278885
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.
Hirsch FR; Varella-Garcia M; Bunn PA; Di Maria MV; Veve R; Bremmes RM; Barón AE; Zeng C; Franklin WA
J Clin Oncol; 2003 Oct; 21(20):3798-807. PubMed ID: 12953099
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer.
Temam S; Kawaguchi H; El-Naggar AK; Jelinek J; Tang H; Liu DD; Lang W; Issa JP; Lee JJ; Mao L
J Clin Oncol; 2007 Jun; 25(16):2164-70. PubMed ID: 17538160
[TBL] [Abstract][Full Text] [Related]
16. EGFR expression in vulvar cancer: clinical implications and tumor heterogeneity.
de Melo Maia B; Fontes AM; Lavorato-Rocha AM; Rodrigues IS; de Brot L; Baiocchi G; Stiepcich MM; Soares FA; Rocha RM
Hum Pathol; 2014 May; 45(5):917-25. PubMed ID: 24746196
[TBL] [Abstract][Full Text] [Related]
17. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.
Mendrzyk F; Korshunov A; Benner A; Toedt G; Pfister S; Radlwimmer B; Lichter P
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2070-9. PubMed ID: 16609018
[TBL] [Abstract][Full Text] [Related]
18. EGFR gene copy number heterogeneity in fine-needle aspiration cytology from breast carcinomas determined by chromogenic in situ hybridization.
Sauer T; Beraki K; Noren T; Garred O; Naess O
Diagn Cytopathol; 2005 Oct; 33(4):228-32. PubMed ID: 16138375
[TBL] [Abstract][Full Text] [Related]
19. EGFR genomic gain and aberrant pathway signaling in pancreatic cancer patients.
Tzeng CW; Frolov A; Frolova N; Jhala NC; Howard JH; Vickers SM; Buchsbaum DJ; Heslin MJ; Arnoletti JP
J Surg Res; 2007 Nov; 143(1):20-6. PubMed ID: 17950068
[TBL] [Abstract][Full Text] [Related]
20. Frequent intratumoral heterogeneity of EGFR gene copy gain in non-small cell lung cancer.
Grob TJ; Hoenig T; Clauditz TS; Atanackovic D; Koenig AM; Vashist YK; Klose H; Simon R; Pantel K; Izbicki JR; Bokemeyer C; Sauter G; Wilczak W
Lung Cancer; 2013 Mar; 79(3):221-7. PubMed ID: 23238037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]